CPT Code for Pap Smear: Accurate Coding, Billing, and Reimbursement Tips

This guide walks through the CPT codes tied to Pap smears, how they interact with collection codes, lab codes, and screening guidelines, and what billers can do to stop leaving money on the table.

Why Pap Smear Coding Feels More Complicated Than It Should Be

A Pap smear isn’t really billed under one single “Pap smear code.” It’s actually a chain of codes working together: a code for the office visit or collection, a code for the lab processing the specimen, and sometimes an additional code for HPV co-testing. Layer on top of that the fact that Medicare uses its own G-codes instead of standard CPT in many screening scenarios, and you’ve got a recipe for confusion even among experienced coders.

Add to this the patient’s risk category average risk versus high risk changes the allowed frequency for Medicare beneficiaries and you start to see why so many practices end up with a stack of denials labeled “frequency limit exceeded” or “service not covered, screening too soon.”

The Core CPT Codes Involved in Pap Smear Billing

Collection of the Specimen

The actual act of collecting the Pap smear sample is typically bundled into the evaluation and management (E/M) visit code, especially when performed during a well-woman exam. There isn’t usually a separate stand-alone CPT code billed by the provider purely for “swabbing” the collection is considered part of the pelvic exam component of the visit.

However, when the visit is purely a preventive screening visit, codes such as 99381–99397 (preventive medicine services, by age and new/established patient status) often capture the encounter, with the Pap collection rolled into that service.

Laboratory Codes for Cytopathology

This is where most of the “real” Pap smear CPT codes live, since the lab is the entity actually billing for analyzing the slide or vial. The most common codes include:

• 88141 Cytopathology, cervical or vaginal, requiring interpretation by physician
• 88142 Cytopathology, cervical or vaginal, thin-layer preparation, manual screening
• 88143 Same as above, manual screening and rescreening
• 88147 Cytopathology, cervical or vaginal, automated thin-layer preparation, screening
• 88148 Automated thin-layer preparation with manual rescreening
• 88150 Cytopathology, smears, cervical or vaginal, manual screening under physician supervision
• 88152 Manual screening with computer-assisted rescreening
• 88153 Manual screening and rescreening with physician interpretation
• 88164–88167 Various manual screening codes under the Bethesda system reporting
• 88174-88175 Automated thin-layer preparation with screening, with or without manual rescreening

For most modern liquid-based Pap tests (ThinPrep, SurePath), 88142 or 88175 tend to be the most frequently used, depending on whether automated screening technology was used.

HPV Co-Testing Codes

Since HPV co-testing has become standard practice for many age groups, billers often need to append codes such as 87624 (HPV high-risk types) or 87625 (HPV types 16 and 18) alongside the cytopathology code, when the lab performs both tests on the same specimen.

Medicare’s G-Codes: The Curveball

Here’s where things get genuinely confusing for anyone newer to gynecologic billing. Medicare does not always use the standard CPT codes listed above for screening Pap smears. Instead, Medicare often requires HCPCS G-codes for the screening pelvic exam and collection:

• G0101 cervical or vaginal cancer screening; pelvic and clinical breast examination
• G0124 screening cytopathology, cervical or vaginal, requiring interpretation by physician
• Q0091 screening Pap smear; obtaining, preparing, and conveyance of cervical or vaginal smear to laboratory

These G-codes and Q-codes exist specifically because Medicare treats screening Pap smears differently from diagnostic ones. A diagnostic Pap smear ordered because a patient has symptoms, an abnormal prior result, or a known condition typically reverts to standard CPT cytopathology codes like 88142 or 88175, paired with an appropriate ICD-10 diagnosis code.

Screening vs. Diagnostic: The Distinction That Decides Everything

This single distinction is this Pap smear a screening test or a diagnostic test drives almost every downstream coding and reimbursement decision. Get it wrong, and the claim either denies outright or pays at the wrong rate.

Screening Pap smears are performed on asymptomatic patients as part of routine preventive care. These are governed by frequency limits:

• Medicare allows a screening Pap smear every 24 months for average-risk patients
• Every 12 months for patients considered high-risk (history of abnormal Pap results, certain risk factors, or other qualifying criteria)

Diagnostic Pap smears are ordered when a patient has symptoms (abnormal bleeding, pelvic pain) or a history that warrants closer monitoring (prior abnormal cytology, HPV-positive status under surveillance). These do not face the same frequency restrictions and are billed using standard CPT codes alongside a relevant ICD-10 code such as N87.x (dysplasia of cervix) or R87.6xx (abnormal cytologic findings in specimens from cervix uteri).

Billers should always confirm with the ordering provider’s documentation why the Pap was performed. A note that simply says “annual exam, Pap collected” supports a screening claim. A note that says “patient with history of CIN II, follow-up Pap performed” supports a diagnostic claim and that distinction changes which codes, modifiers, and frequency rules apply.

Modifiers That Frequently Come Into Play

A few modifiers show up repeatedly in Pap smear claims and are worth knowing cold:

• Modifier 25 used on an E/M code when a significant, separately identifiable service was performed on the same day as a preventive visit (for example, the patient came in for an annual exam but also had a problem addressed that required additional E/M work)
• Modifier 33 indicates a preventive service, which can affect whether the patient owes a copay under ACA preventive care rules
• Modifier TC / 26 technical component versus professional component, relevant when the lab and the interpreting physician bill separately for cytopathology services

Common Denial Reasons and How to Prevent Them

Frequency Limit Denials

By far the most common denial for Pap smear claims tied to Medicare and many commercial payers. The fix starts before the claim is ever submitted check the patient’s history for the date of the last Pap smear and confirm their risk category is documented correctly. If a patient was previously coded as “high risk” but the most recent visit doesn’t reflect ongoing risk factors, payers may default to the 24-month rule, triggering a denial for a Pap performed at the 12-month mark.

Bundling Issues

Some payers bundle the collection into the E/M visit and will deny a separately billed collection code as part of a global preventive service. Reviewing each payer’s specific bundling edits not just CMS’s National Correct Coding Initiative (NCCI) edits helps avoid these denials, since commercial payer policies can diverge from Medicare’s approach.

Incorrect Code Selection for Specimen Type

Billing 88142 (manual screening) when the lab actually used automated screening technology appropriate for 88175 is a surprisingly frequent error, especially in practices that send specimens to labs using different platforms for different patients. Coordinating with the lab to confirm exactly which code matches their processing method avoids this mismatch.

Missing or Mismatched ICD-10 Codes

A diagnostic Pap smear billed with a screening ICD-10 code (Z12.4, encounter for screening for malignant neoplasm of cervix) when the documentation actually supports a diagnostic reason will often get flagged. Conversely, billing a routine screening visit with a diagnostic ICD-10 code can trigger unnecessary patient cost-sharing under preventive care rules, leading to patient complaints and appeals.

Tips for Cleaner Pap Smear Claims

Verify the patient’s risk category at every visit risk status isn’t a one-time designation it should be reassessed and documented at each encounter, since it directly affects which frequency rules apply.

Confirm payer-specific code requirements before submission medicare’s G0101/G0124/Q0091 combination doesn’t apply universally; many commercial payers want standard CPT codes even for preventive Pap smears. Building payer-specific cheat sheets into the workflow saves enormous time.

Align diagnosis codes with documented intent if the provider’s note says “routine annual exam,” the ICD-10 code should reflect a screening encounter (Z01.4 or Z12.4, depending on context), not a diagnostic code pulled from an old problem list.

Coordinate with the lab on cytopathology code selection since the lab typically submits the cytopathology claim independently, mismatches between what the ordering provider expects and what the lab actually bills can create confusing patient statements and reconciliation headaches.

Stay current on HPV co-testing guidelines as clinical guidelines around HPV co-testing intervals continue to shift, payer policies sometimes lag or diverge from current clinical recommendations leading to denials for co-testing performed “too early” according to a payer’s outdated frequency table.

Audit denial patterns quarterly. A recurring denial reason say, frequency limits hitting the same handful of patients repeatedly often points to a documentation gap in how risk status is being recorded, not a one-off billing mistake.